Differential use of CCR5 by HIV-1 clinical isolates resistant to small molecule CCR5 inhibitors

被引：0
|
作者：
Henrich, T. J. [1 ,2 ]
Lewine, N. [3 ]
Lee, S-H [1 ,4 ]
Rao, S. [3 ]
Berro, R. [5 ]
Greaves, W. [6 ]
Gulick, R.
Tsibris, A. [2 ,7 ]
Moore, J. [5 ]
Kuritzkes, D. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Harvard Univ, Cambridge, MA 02138 USA
[4] Pusan Natl Univ, Pusan, South Korea
[5] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[6] Schering Plough Res Inst, Kenilworth, NJ USA
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
ANTIVIRAL THERAPY | 2011年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
46
引用
收藏
页码：A59 / A59
页数：1
相关论文
共 50 条
  • [1] Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists
    Henrich, Timothy J.
    Lewine, Nicolas R. P.
    Lee, Sun-Hee
    Rao, Suhas S. P.
    Berro, Reem
    Gulick, Roy M.
    Moore, John P.
    Tsibris, Athe M. N.
    Kuritzkes, Daniel R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (04) : 1931 - 1935
  • [2] Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry
    Berro, Reem
    Sanders, Rogier W.
    Lu, Min
    Klasse, Per J.
    Moore, John P.
    PLOS PATHOGENS, 2009, 5 (08)
  • [3] HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry
    Pugach, Pavel
    Marozsan, Andre J.
    Ketas, Thomas J.
    Landes, Elissa L.
    Moore, John P.
    Kuhmann, Shawn E.
    VIROLOGY, 2007, 361 (01) : 212 - 228
  • [4] Interaction of small molecule inhibitors of HIV-1 entry with CCR5
    Seibert, Christoph
    Ying, Weiwen
    Gavrilov, Svetlana
    Tsamis, Fotini
    Kuhmann, Shawn E.
    Palani, Anandan
    Tagat, Jayaram R.
    Clader, John W.
    McCombie, Stuart W.
    Baroudy, Bahige M.
    Smith, Steven O.
    Dragic, Tatjana
    Moore, John P.
    Sakmar, Thomas P.
    VIROLOGY, 2006, 349 (01) : 41 - 54
  • [5] HIV-1 escape from small molecule CCR5 inhibitors in vitro
    Kuhmann, Shawn
    RETROVIROLOGY, 2005, 2 (Suppl 1)
  • [6] HIV-1 Escape From Small Molecule CCR5 Inhibitors In Vitro
    Shawn Kuhmann
    Retrovirology, 2
  • [7] CCR5 Utilization of Transmitted and Early Founder HIV-1 Envelopes and the Sensitivity to Small CCR5 Inhibitors
    Hu, Q.
    Keele, B.
    Ping, L.
    Grayson, T.
    Sun, C.
    Hahn, B.
    Shattock, R.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 6 - 6
  • [8] CCR5 inhibitors in HIV-1 therapy
    Dorr, Patrick
    Perros, Manos
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (11) : 1345 - 1361
  • [9] Clinical use of CCR5 inhibitors in HIV and beyond
    Bruce L Gilliam
    David J Riedel
    Robert R Redfield
    Journal of Translational Medicine, 9
  • [10] Clinical use of CCR5 inhibitors in HIV and beyond
    Gilliam, Bruce L.
    Riedel, David J.
    Redfield, Robert R.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
12345